30 July 2026
NOTICE OF AMENDED AND RESTATED PRICING SUPPLEMENT
WELLS FARGO FINANCE LLC
U.S.$10,000,000,000
Euro Medium Term Note Programme
Fully and unconditionally guaranteed by Wells Fargo & Company
(a) AUD 2,000,000 5.75 per cent. Notes due 9 April 2041 (Series No.: 86, Tranche No.: 1) (ISIN: XS3334285809; Common Code: 333428580) (the "Series 86 (Tranche 1) Notes"); and
(b) AUD 2,000,000 5.75 per cent. Notes due 9 April 2041 (Series No.: 86, Tranche No.: 2) (ISIN: XS3334285809; Common Code: 333428580) (the "Series 86 (Tranche 2) Notes")
(together, the "Notes")
This notice ("Notice") is supplemental to, and should be construed together with:
(i) in respect of the Series 86 (Tranche 1) Notes, the Amended and Restated Pricing Supplement dated 7 April 2026 (the "Original Series 86 (Tranche 1) Pricing Supplement"); and
(ii) in respect of the Series 86 (Tranche 2) Notes, the Pricing Supplement dated 27 July 2026 (the "Original Series 86 (Tranche 2) Pricing Supplement").
The Issuer hereby gives notice to holders of the relevant Notes that, with effect from the date of this Notice,
i. the Original Series 86 (Tranche 1) Pricing Supplement relating to the Series 86 (Tranche 1) Notes has been amended and restated (the "Amended and Restated Series 86 (Tranche 1) Pricing Supplement"); and
ii. the Original Series 86 (Tranche 2) Pricing Supplement relating to the Series 86 (Tranche 2) Notes has been amended and restated (the "Amended and Restated Series 86 (Tranche 2) Pricing Supplement")
(each, an "Amended and Restated Pricing Supplement").
Specifically, for the purpose of correcting a manifest error,
(1) in respect of the Series 86 (Tranche 1) Notes, the item "Fixed Coupon Amount(s)" in sub-paragraph (ii) of paragraph 18 (Fixed Rate Note Provisions) contained in "Part A - Contractual Terms" of the Original Series 86 (Tranche 1) Pricing Supplement shall be deleted in its entirety and replaced with the following:
"(ii)
Fixed Coupon Amount(s):
Not Applicable"; and
(2) in respect of the Series 86 (Tranche 2) Notes, the item "Fixed Coupon Amount(s)" in sub-paragraph (ii) of paragraph 18 (Fixed Rate Note Provisions) contained in "Part A - Contractual Terms" of the Original Series 86 (Tranche 2) Pricing Supplement shall be deleted in its entirety and replaced with the following:
"(ii)
Fixed Coupon Amount(s):
Not Applicable".
To view the full document, please paste the following URL into the address bar of your browser:
Amended and Restated Series 86 (Tranche 1) Pricing Supplement
http://www.rns-pdf.londonstockexchange.com/rns/6302O_1-2026-7-30.pdf
Amended and Restated Series 86 (Tranche 2) Pricing Supplement
http://www.rns-pdf.londonstockexchange.com/rns/6302O_2-2026-7-30.pdf
WELLS FARGO FINANCE LLC
For further information, please contact
John Beer
Senior Company Counsel
Wells Fargo Finance LLC
+1-415-396-5826
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the relevant Amended and Restated Pricing Supplement and/or the information memorandum dated 27 March 2026 relating to the above-mentioned Notes (the "Information Memorandum") may be addressed to and/or targeted at persons who are residents of particular countries (specified in the relevant Amended and Restated Pricing Supplement and/or the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the relevant Amended and Restated Pricing Supplement and/or the Information Memorandum is not addressed. Prior to relying on the information contained in the relevant Amended and Restated Pricing Supplement and/or the Information Memorandum you must ascertain from the relevant Amended and Restated Pricing Supplement and/or the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DOCBUGDRUSXDGLG